Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trials.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples